Welcome to our dedicated page for National Vision Holdings SEC filings (Ticker: EYE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
National Vision Holdings, Inc. filings document the regulatory record for a Nasdaq-listed optical retailer with common stock registered under the Exchange Act. Its Form 8-K reports furnish quarterly and annual financial results, financial-condition updates and material events tied to the company’s retail eyewear and eye-care business.
Proxy and annual-meeting filings cover board elections, stockholder voting matters, executive-compensation governance and other corporate-governance disclosures. The filing record also includes material definitive agreements, such as amendments to the company’s letter agreement with Essilor of America, as well as board composition, succession-related disclosures and the company’s capital-stock registration details.
National Vision Holdings, Inc. (EYE) – Form 4 filing dated 06/23/2025
Director Susan C. O’Farrell reported the award of 9,674 restricted stock units (RSUs) on 06/18/2025. Each RSU converts into one share of common stock and will vest 100 % on the first anniversary of the grant date. The grant was recorded at $0 acquisition cost, indicating it is an equity-based compensation award rather than an open-market purchase.
Following the grant, O’Farrell’s total beneficial ownership increased to 22,333 shares, all held directly. No derivative securities or sales were disclosed. The transaction modestly increases insider alignment with shareholders, while the share count involved is immaterial relative to EYE’s outstanding shares and therefore has no meaningful dilutive impact.
National Vision Holdings, Inc. (EYE) filed a Form 4 disclosing that director Michael J. Nicholson received 7,392 restricted stock units (RSUs) on 06/18/2025. Each RSU converts into one common share upon vesting, which occurs in full on the first anniversary of the grant date. The award was issued at $0 cost to the director and did not involve an open-market transaction. Following the grant, Nicholson’s total beneficial ownership increased to 10,719 common shares, all held directly. No derivative securities or simultaneous dispositions were reported.
This is a routine equity compensation grant aimed at aligning board member incentives with shareholder interests. The transaction represents approximately 0.01% of EYE’s ~80 million shares outstanding, so market impact is expected to be minimal.
National Vision Holdings, Inc. (EYE) – Form 4 filing overview:
Director James M. McGrann reported the grant of 7,392 restricted stock units (RSUs) on 18 June 2025. Each RSU represents the right to receive one share of common stock and will vest in full on the first anniversary of the grant date. Following the award, McGrann’s direct beneficial ownership rises to 10,719 shares. The transaction was coded “A” (acquired) and carries a price of $0, indicating it is part of routine director compensation rather than an open-market purchase.
No derivative securities were reported, and there are no indications of sales or dispositions. The disclosure is single-person, routine, and compensation-related, with limited immediate market impact.
National Vision Holdings (EYE) – Form 4 filing overview: On 06/18/2025, independent director Naomi Kelman received an equity award of 7,392 restricted stock units (RSUs), each convertible into one share of common stock. The RSUs were granted at $0 cost and will vest in full on the first anniversary of the grant date, subject to continued service. Following the award, Kelman’s total direct beneficial ownership increased to 41,041 shares.
No shares were sold and no cash was exchanged, indicating the transaction is a routine annual equity grant designed to align director incentives with shareholder interests. No derivative positions or additional transactions were reported.
National Vision Holdings, Inc. (EYE) – Form 4 insider filing
Director Susan S. Johnson reported the award of 7,392 restricted stock units (RSUs) on 18 June 2025. Each RSU represents the right to receive one share of common stock upon vesting. According to the filing, these RSUs vest in full on the first anniversary of the grant date, aligning the director’s compensation with long-term shareholder value. No cash was paid for the units (reported price $0), indicating a standard equity incentive grant rather than an open-market purchase. Following the award, Johnson’s total beneficial ownership stands at 43,700 shares, all held directly.
The filing was signed on 23 June 2025 by attorney-in-fact Jared Brandman and contains no indication of share sales, option exercises or transfers. There are also no derivative transactions disclosed in Table II, suggesting the director’s exposure is limited to common stock and outstanding equity awards.
While Form 4s do not provide company-wide financial data, incremental insider accumulation can serve as a sentiment indicator. However, given the modest size relative to National Vision’s ~83 million share float (per last 10-K), the transaction is unlikely to be financially material to the enterprise. Investors may view the grant as routine board compensation rather than a signal of imminent corporate developments.